ABCB1 and neoplasm: The up-regulation of ABCB1 in the tumor cell population of the cluster group with longer PFS at the six-week timepoint compared to the initial timepoint supports previous research implicating ABCB1 in acquired multi-drug resistance and relapse in cL.